These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18885)

  • 1. Regional and ultrastructural localization of tyrosine hydroxylass by immunocytochemistry in dopaminergic neurons of the mesolimbic and nigroneostriatal systems.
    Pickel VM; Joh TH; Reis DJ
    Adv Biochem Psychopharmacol; 1977; 16():321-9. PubMed ID: 18885
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic changes in the activities and amounts of neurotransmitter-synthesizing enzymes in mesolimbic and other central catecholamine neurons in response to axonal injury and during collateral sprouting.
    Reis DJ; Gilad GM; Pickel VM; Ross RA; Joh TH
    Adv Biochem Psychopharmacol; 1977; 16():331-41. PubMed ID: 18886
    [No Abstract]   [Full Text] [Related]  

  • 3. Do axons of nigro-neostriatal dopamine neurons contain acetylcholinesterase?
    Butcher LL
    Proc West Pharmacol Soc; 1976; 19():102-7. PubMed ID: 995972
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopaminergic neurons: effects of electrical stimulation on tyrosine hydroxylase.
    Murrin LC; Morgenroth VH; Roth RH
    Mol Pharmacol; 1976 Nov; 12(6):1070-81. PubMed ID: 12461
    [No Abstract]   [Full Text] [Related]  

  • 5. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats.
    Wictorin K; Brundin P; Sauer H; Lindvall O; Björklund A
    J Comp Neurol; 1992 Sep; 323(4):475-94. PubMed ID: 1358925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
    Julou L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for descending pallido-nigral GABA-containing neurons.
    McGeer PL; Fibiger HC; Maler L; Hattori T; McGeer EG
    Adv Neurol; 1974; 5():153-60. PubMed ID: 4155231
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice.
    Hitzemann R; Qian Y; Hitzemann B
    J Pharmacol Exp Ther; 1993 Jul; 266(1):431-8. PubMed ID: 8101223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral implications of dopaminergic neurons in the mesolimbic system.
    Iversen SD; Koob GF
    Adv Biochem Psychopharmacol; 1977; 16():209-14. PubMed ID: 560790
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: properties and localization in dopaminergic neurons.
    Lehmann J; Fibiger HC
    J Neurochem; 1978 Mar; 30(3):615-24. PubMed ID: 681936
    [No Abstract]   [Full Text] [Related]  

  • 12. Axonal transport of protein in the nigro-neostriatal pathway of rats after chronic amphetamine.
    Craves FB; Iwamoto ET; Loh HH
    Proc West Pharmacol Soc; 1976; 19():142-6. PubMed ID: 995979
    [No Abstract]   [Full Text] [Related]  

  • 13. Localization of cholecystokinin receptors in relation to the nigrostriatal and mesolimbic dopaminergic pathways.
    Gaudreau P; Quirion R; St-Pierre S; Chiueh CC; Pert A
    Neuropeptides; 1987; 9(4):283-93. PubMed ID: 3614556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of the midbrain dopaminergic pathways during mouse development.
    Hu Z; Cooper M; Crockett DP; Zhou R
    J Comp Neurol; 2004 Aug; 476(3):301-11. PubMed ID: 15269972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomical organization of the corpus striatum and related nuclei.
    Carpenter MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():1-36. PubMed ID: 826993
    [No Abstract]   [Full Text] [Related]  

  • 16. Striatal infarction in the rat causes a transient reduction of tyrosine hydroxylase immunoreactivity in the ipsilateral substantia nigra.
    Soriano MA; Justicia C; Ferrer I; Rodríguez-Farré E; Planas AM
    Neurobiol Dis; 1997; 4(5):376-85. PubMed ID: 9440126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 18. Single dopaminergic nigrostriatal neurons form two chemically distinct synaptic types: possible transmitter segregation within neurons.
    Hattori T; Takada M; Moriizumi T; Van der Kooy D
    J Comp Neurol; 1991 Jul; 309(3):391-401. PubMed ID: 1717519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats.
    Creutz LM; Kritzer MF
    J Comp Neurol; 2004 Aug; 476(4):348-62. PubMed ID: 15282710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evidence for localization of NMDAR1 receptor subunit on dopaminergic neurons of the rat substantia nigra, pars compacta.
    Wedzony K; Czepiel K; Fijał K
    Pol J Pharmacol; 2001; 53(6):675-9. PubMed ID: 11985345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.